Protective effects of pseudoginsenoside-F11 on methamphetamine-induced neurotoxicity in mice

Pharmacology Biochemistry and Behavior

Volumn 76, Issue 1, 2003, Pages 103-109

  Wu, Chun Fu ^a   Liu, Yan Li ^a   Song, Ming ^b   Liu, Wen ^a   Wang, Jin Hui ^a   Li, Xian ^a   Yang, Jing Yu ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b Liaoning Institute of Crime Detectives   (China)

Author keywords

Anxiety; Depression; Dopamine; Memory impairment; Methamphetamine; Neurotoxicity; PF11

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; METHAMPHETAMINE; PSEUDOGINSENOSIDE F 11; SAPONIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; IMMOBILIZATION; LIGHT DARK CYCLE; MALE; MAZE TEST; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SWIMMING; TASK PERFORMANCE;

ANIMALS; ANXIETY; ESCAPE REACTION; GINSENOSIDES; MALE; MAZE LEARNING; METHAMPHETAMINE; MICE; NEUROPROTECTIVE AGENTS; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; SAPONINS;

PANAX GINSENG; PANAX QUINQUEFOLIUS;

EID: 1642378970     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(03)00215-6     Document Type: Article

References (36)

1. Cadet J.L., Ali S.F., Rothman R.B., Epstein C.J. Neurotoxicity, drugs and abuse and the Cu Zn-superoxide dismutase transgenic mice. Mol. Neurobiol. 11:1995;155-163.
2. Chen S.E., Staba E.J., Taniyasu S., Kasai R., Tanaka O. Further study on dammarane-saponins of leaves and stems of American ginseng, Panax quinquefolium. Planta Med. 42:1981;406-411.
3. Chen D., Wu C.F., Shi B., Xu Y.M. Tamoxifen and toremifene cause impairment of learning and memory in mice. Pharmacol. Biochem. Behav. 71:2002;269-276.
4. Cho A.K., Melega W.P. Patterns of methamphetamine abuse and their consequences. J. Addict. Dis. 21:2002;21-34.
5. Dazzi L., Spiga F., Pira L., Ladu S., Vacca G., Rivano A.et al. Inhibition of stress- or anxiogenic-drug induced increases in dopamine release in the rat prefrontal cortex by long-term treatment with antidepressant drugs. J. Neurochem. 76:2001;1212-1220.
6. Ellison G., Eison M.S., Huberman H.S., Daniel F. Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. Science. 201:1978;276-278.
7. Fornai F., Vaglini F., Maggio R., Bonuccelli U., Corsini G.U. Species differences in the role of excitatory amino acids in experimental parkinsonism. Neurosci. Biobehav. Rev. 21:1997;401-415.
8. Hotchkiss A.J., Morgan M.E., Gibb J.W. The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities. Life Sci. 25:1979;1373-1378.
9. Imam S.Z., Newport G.D., Islam F., Slikker W. Jr., Ali S.F. Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity. Brain Res. 818:1999;575-578.
10. Imam S.Z., el-Yazal J., Newport G.D., Itzhak Y., Cadet J.L., Slikker W. Jr.et al. Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts. Ann. N. Y. Acad. Sci. 939:2001;366-380.
11. Johnson M., Elayan I., Hanson G.R., Foltz R.L., Gibb J.W., Lim H.K. Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine on central serotonergic and dopaminergic systems. J. Pharmacol. Exp. Ther. 261:1992;447-453.
12. Kolecki P. Inadvertent methamphetamine poisoning in pediatric patients. Pediatr. Emerg. Care. 14:1998;385-387.
13. 11 on scopolamine induced memory impairment in mice and rats. J. Pharm. Pharmacol. 51:1999;435-440.
14. 11 on the behavioral actions of morphine in mice. Pharmacol. Biochem. Behav. 66:2000;595-601.
15. 11 attenuates morphine-induced signaling in Chinese hamster ovary-μ cells. NeuroReport. 12:2001;1453-1456.
16. Li Z., Wu C.F., Pei G., Xu N.J. Reversal of morphine-induced memory impairment in mice by withdrawal in Morris water maze: possible involvement of cholinergic system. Pharmacol. Biochem. Behav. 68:2001;507-513.
17. Martinot M., Bragulat V., Artiges E., Dolle F., Hinnen F., Jouvent R.et al. Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation. Am. J. Psychiatry. 158:2001;314-316.
18. Morley K.C., Gallate J.E., Hunt G.E., Mallet P.E., McGregor I.S. Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy"). Eur. J. Pharmacol. 433:2001;91-99.
19. Nakagawa T., Ukai K., Ohyama T., Gomita Y., Okamura H. Effects of dopaminergic agents on reversal of reserpine-induced impairment in conditioned avoidance response in rats. Pharmacol. Biochem. Behav. 58:1997;829-836.
20. Oh K.W., Kim H.S., Wagner G.C. Ginseng total saponin inhibits the dopaminergic depletions induced by methamphetamine. Planta Med. 63:1997;80-81.
21. Ornstein T.J., Iddon J.L., Baldacchino A.M., Sahakian B.J., London M., Everitt B.J.et al. Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology. 23:2000;113-126.
22. Ricaurte G.A., Guillery R.W., Seiden L.S., Schuster C.R., Moore R.Y. Dopamine nerve terminal degeneration produced by high doses of methamphetamine in the rat brain. Brain Res. 235:1982;93-103.
23. Robinson T.E., Castaneda E., Whishaw I.Q. Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or methamphetamine: a review of evidence from microdialysis studies. Can. J. Psychol. 44:1990;253-275.
24. Seiden L.S., Fischman M.W., Schuster C.R. Long-term effects of multiple induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend. 1:1975;215-221.
25. Simon S.L., Domier C.P., Sim T., Richardson K., Rawson R.A., Ling W. Cognitive performance of current methamphetamine and cocaine abusers. J. Addict. Dis. 21:2002;61-74.
26. Strupp B.J., Bunsey M., Levitsky D., Kesler M. Time-dependent effects of post-trial amphetamine treatment in rats: evidence for enhanced storage of representational memory. Behav. Neural Biol. 56:1991;62-76.
27. 2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients. Pharmacogenetics. 11:2001;545-550.
28. Tanaka O., Yahara S. Dammarane saponins of leaves of Panax pseudoginseng subsp. himalaicus. Phytochemistry. 17:1978;1353-1358.
29. Tanila H., Bjorklund M., Riekkinen P. Jr. Cognitive changes in mice following moderate MPTP exposure. Brain Res. Bull. 45:1998;577-582.
30. Tokuyama S., Oh K.W., Kim H.S., Takahashi M., Kaneto H. Blockade by ginseng extract of the development of reverse tolerance to the ambulation-accelerating effect of methamphetamine in mice. Jpn. J. Pharmacol. 59:1992;423-425.
31. Tokuyama S., Takahashi M., Kaneto H. The effect of ginseng extract on locomotor sensitization and conditioned place preference induced by methamphetamine and cocaine in mice. Pharmacol. Biochem. Behav. 54:1996;671-676.
32. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Leonido-Yee M., Franceschi D.et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am. J. Psychiatry. 158:2001;377-382.
33. Vorhees C.V. Developmental neurotoxicity induced by therapeutic and illicit drugs. Environ. Health Perspect. 102(Suppl. 2):1994;145-153.
34. Watanabe C., Satoh H. Effects of prolonged selenium deficiency on open field behavior and Morris water-maze performance in mice. Pharmacol. Biochem. Behav. 51:1995;747-752.
35. Yamanaka Y., Takano R., Egashira T. Methamphetamine-induced behavioral alterations following repeated administration of methamphetamine. Jpn. J. Pharmacol. 41:1986;147-154.
36. Yates G., Panksepp J., Ikemoto S., Nelson E., Conner R. Social isolation effects on the "behavioral despair" forced swimming test: effect of age and duration of testing. Physiol. Behav. 49:1991;347-353.